Latest News
The Inflation Reduction Act’s Medicare Drug Price Negotiation Program updated
The Inflation Reduction Act of 2022 included several provisions to lower Medicare drug costs by requiring the Secretary of Health and Human Services (HHS) to negotiate prices with drug companies for certain drugs covered under Medicare Part D. Juliette Cubanski for The Kaiser Family Foundation has published a FAQ about the Inflation Reduction Act’s Medicare Drug Price Negotiation Program. Click here to be redirected to this article.
This posting is presented for informational purposes only and does not represent legal or financial guidance. Any opinions or interpretations presented are either those of the original author or, in the case of articles authored by the AMAC Foundation, are the opinions of AMAC Foundation staff, originally trained and accredited by the National Social Security Association (NSSA) and certified via the AMAC Foundation. Any links included in the article are valid on the posted date; socialsecurityreport.org cannot guarantee the duration of the links’ validity. NSSA and the AMAC Foundation and its staff are not affiliated with or endorsed by the Social Security Administration or any other governmental entity. To submit a question, visit our website (https://amacfoundation.org/services/) or email us at ssadvisor@amacfoundation.org. Because we are a non-profit organization, there is no charge for these services.